These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22228770)

  • 21. Orphan Nuclear Receptor Nur77 Inhibits Cardiac Hypertrophic Response to Beta-Adrenergic Stimulation.
    Yan G; Zhu N; Huang S; Yi B; Shang X; Chen M; Wang N; Zhang GX; Talarico JA; Tilley DG; Gao E; Sun J
    Mol Cell Biol; 2015 Oct; 35(19):3312-23. PubMed ID: 26195821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure.
    Bisping E; Ikeda S; Kong SW; Tarnavski O; Bodyak N; McMullen JR; Rajagopal S; Son JK; Ma Q; Springer Z; Kang PM; Izumo S; Pu WT
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14471-6. PubMed ID: 16983087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimerization of the GATA4 transcription factor regulates transcriptional activity and cardiomyocyte hypertrophic response.
    Shimizu S; Sunagawa Y; Hajika N; Yorimitsu N; Katanasaka Y; Funamoto M; Miyazaki Y; Sari N; Shimizu K; Hasegawa K; Morimoto T
    Int J Biol Sci; 2022; 18(3):1079-1095. PubMed ID: 35173540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GATA4 expression is primarily regulated via a miR-26b-dependent post-transcriptional mechanism during cardiac hypertrophy.
    Han M; Yang Z; Sayed D; He M; Gao S; Lin L; Yoon S; Abdellatif M
    Cardiovasc Res; 2012 Mar; 93(4):645-54. PubMed ID: 22219180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of Targeted Pharmacotherapy for Cardiovascular Disease].
    Katanasaka Y
    Yakugaku Zasshi; 2017; 137(11):1349-1353. PubMed ID: 29093370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GATA4-mediated cardiac hypertrophy induced by d-myo-inositol 1,4,5-tris-phosphate.
    Zhu Z; Zhu S; Liu D; Yu Z; Yang Y; van der Giet M; Tepel M
    Biochem Biophys Res Commun; 2005 Dec; 338(2):1236-40. PubMed ID: 16259952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendropanax morbifera Prevents Cardiomyocyte Hypertrophy by Inhibiting the Sp1/GATA4 Pathway.
    Sun S; Li T; Jin L; Piao ZH; Liu B; Ryu Y; Choi SY; Kim GR; Jeong JE; Wi AJ; Lee SJ; Kee HJ; Jeong MH
    Am J Chin Med; 2018; 46(5):1021-1044. PubMed ID: 29986596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TIEG1 Inhibits Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting Transcription Factor GATA4.
    Li Q; Shen P; Zeng S; Liu P
    J Cardiovasc Pharmacol; 2015 Aug; 66(2):196-203. PubMed ID: 26252173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor 1 enhances follicle-stimulating hormone-induced phosphorylation of GATA4 in rat granulosa cells.
    Convissar S; Bennett-Toomey J; Stocco C
    Mol Cell Endocrinol; 2023 Jan; 559():111807. PubMed ID: 36279967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MG53, A Novel Regulator of KChIP2 and I
    Liu W; Wang G; Zhang C; Ding W; Cheng W; Luo Y; Wei C; Liu J
    Circulation; 2019 Apr; 139(18):2142-2156. PubMed ID: 30760025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meox1 accelerates myocardial hypertrophic decompensation through Gata4.
    Lu D; Wang J; Li J; Guan F; Zhang X; Dong W; Liu N; Gao S; Zhang L
    Cardiovasc Res; 2018 Feb; 114(2):300-311. PubMed ID: 29155983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of α-enolase protects cardiomyocytes from phenylephrine-induced hypertrophy.
    Gao S; Liu XP; Wei LH; Lu J; Liu P
    Can J Physiol Pharmacol; 2018 Apr; 96(4):352-358. PubMed ID: 28910549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.
    Le K; Li R; Xu S; Wu X; Huang H; Bao Y; Cai Y; Lan T; Moss J; Li C; Zou J; Shen X; Liu P
    Arch Biochem Biophys; 2012 Feb; 518(1):71-8. PubMed ID: 22198280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible mechanism of GATA4 inhibiting myocardin activity during cardiac hypertrophy.
    Xu Y; Liang C; Luo Y; Xing W; Zhang T
    J Cell Biochem; 2019 Jun; 120(6):9047-9055. PubMed ID: 30582211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA 26b encoded by the intron of small CTD phosphatase (SCP) 1 has an antagonistic effect on its host gene.
    Sowa N; Horie T; Kuwabara Y; Baba O; Watanabe S; Nishi H; Kinoshita M; Takanabe-Mori R; Wada H; Shimatsu A; Hasegawa K; Kimura T; Ono K
    J Cell Biochem; 2012 Nov; 113(11):3455-65. PubMed ID: 22678827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gelsolin (GSN) induces cardiomyocyte hypertrophy and BNP expression via p38 signaling and GATA-4 transcriptional factor activation.
    Hu WS; Ho TJ; Pai P; Chung LC; Kuo CH; Chang SH; Tsai FJ; Tsai CH; Jie YC; Liou YM; Huang CY
    Mol Cell Biochem; 2014 May; 390(1-2):263-70. PubMed ID: 24505034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ZAK induces cardiomyocyte hypertrophy and brain natriuretic peptide expression via p38/JNK signaling and GATA4/c-Jun transcriptional factor activation.
    Hsieh YL; Tsai YL; Shibu MA; Su CC; Chung LC; Pai P; Kuo CH; Yeh YL; Viswanadha VP; Huang CY
    Mol Cell Biochem; 2015 Jul; 405(1-2):1-9. PubMed ID: 25869677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. YQWY decoction reverses cardiac hypertrophy induced by TAC through inhibiting GATA4 phosphorylation and MAPKs.
    Huang JJ; Xie Y; Li H; Zhang XX; Huang Q; Zhu Y; Gu P; Jiang WM
    Chin J Nat Med; 2019 Oct; 17(10):746-755. PubMed ID: 31703755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2) regulates G-protein-coupled receptor kinase 5 (GRK5)-induced cardiac hypertrophy
    Yeh ST; Zambrano CM; Koch WJ; Purcell NH
    J Biol Chem; 2018 May; 293(21):8056-8064. PubMed ID: 29628444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes.
    Chandrasekar B; Mummidi S; Claycomb WC; Mestril R; Nemer M
    J Biol Chem; 2005 Feb; 280(6):4553-67. PubMed ID: 15574430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.